A detailed history of Cx Institutional transactions in Novartis Ag stock. As of the latest transaction made, Cx Institutional holds 10,679 shares of NVS stock, worth $1.11 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
10,679
Previous 10,278 3.9%
Holding current value
$1.11 Million
Previous $1.09 Million 12.25%
% of portfolio
0.05%
Previous 0.05%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$106.13 - $120.89 $42,558 - $48,476
401 Added 3.9%
10,679 $1.23 Million
Q2 2024

Jul 11, 2024

BUY
$92.57 - $107.37 $7,035 - $8,160
76 Added 0.74%
10,278 $1.09 Million
Q1 2024

Apr 15, 2024

SELL
$95.27 - $108.47 $5,049 - $5,748
-53 Reduced 0.52%
10,202 $986,000
Q2 2023

Jul 26, 2023

SELL
$92.52 - $104.91 $8,604 - $9,756
-93 Reduced 0.9%
10,255 $1.03 Million
Q1 2023

May 04, 2023

BUY
$80.03 - $92.81 $11,684 - $13,550
146 Added 1.43%
10,348 $952,000
Q1 2022

May 09, 2022

BUY
$80.11 - $90.62 $110,151 - $124,602
1,375 Added 15.58%
10,202 $895,000
Q4 2021

Jan 18, 2022

SELL
$79.7 - $88.13 $109,587 - $121,178
-1,375 Reduced 13.48%
8,827 $772,000
Q4 2020

Jan 12, 2021

SELL
$78.07 - $94.43 $1,014 - $1,227
-13 Reduced 0.13%
10,202 $963,000
Q3 2020

Oct 13, 2020

SELL
$82.14 - $91.0 $2,546 - $2,821
-31 Reduced 0.3%
10,215 $888,000
Q2 2020

Aug 06, 2020

BUY
$80.93 - $91.1 $13,434 - $15,122
166 Added 1.65%
10,246 $895,000
Q4 2019

Jan 21, 2020

SELL
$84.35 - $95.37 $1,349 - $1,525
-16 Reduced 0.16%
10,080 $954,000
Q3 2019

Oct 10, 2019

SELL
$85.54 - $94.26 $2,480 - $2,733
-29 Reduced 0.29%
10,096 $877,000
Q2 2019

Jul 17, 2019

SELL
$75.4 - $92.8 $20,207 - $24,870
-268 Reduced 2.58%
10,125 $925,000
Q1 2019

Apr 03, 2019

BUY
$75.32 - $86.15 $24,554 - $28,084
326 Added 3.24%
10,393 $999,000
Q4 2018

Jan 14, 2019

BUY
$73.66 - $82.02 $741,535 - $825,695
10,067 New
10,067 $864,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Cx Institutional Portfolio

Follow Cx Institutional and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cx Institutional, based on Form 13F filings with the SEC.

News

Stay updated on Cx Institutional with notifications on news.